20150129 smb nemo healthcare

Science meets Business Health technology assessment

January 29, 2015 Confidential

Safe births Healthy children

Ambition: What if we could reduce birth asphyxia with 50%?

• Save 20.000 newborns yearly from starting with a handicap

• Deliver €10B cost of care savings to society

• Build a great enterprise with €100M+ revenues

Confidential

Guess what, we can!

But HOW to achieve that goal???

What we believe (and know, of

course...)

1) We are the best, we can do this...

2) Yes, absolutely, you need to invest in us...

3) This is huge...

4) It will be all right, trust me...

Confidential

What ‘they’ see...

Technology development takes (too) long... Underfunded, but they get there: CE marking (2013) They’re halfway there... Now prove they can sell...

Confidential

1) We need users (to prove we can sell)

2) Users want scientific proof

3) We need users to provide scientific proof... See 1)

Confidential

Paradox

Vicious circle

Confidential

How to break these chains?

Health technology assessment

Confidential

MedValue Technology assessment

What can PUREtrace bring:

• Cost savings?

• Reduce C-sections?

• Convince decision makers?

• ...

Confidential

CTG tracing showed drop in FHR (blue arrow), emergency C-section would be logical next step. PUREtrace indicated non-relaxing uterine muscle (red arrow). Oxytocin was stopped and the fetus recovered. Eventually, the child was delivered vaginally (data MMC Veldhoven).

Data from HIS MMC Veldhoven

Confidential

Example

Output • Independent proof

through solid research

• Radboud UMC connected

• Access to insurers

• Validation options

• Network

• ...

Confidential

HTA provides

• Early stage screening

• Early stage proof (at limited costs)

• Independent support

• Improvement plans

Confidential

HISTORY Confidential